DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic Stroke

NATerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 12, 2022

Primary Completion Date

July 20, 2023

Study Completion Date

August 4, 2023

Conditions
Acute Ischemic Stroke
Interventions
DEVICE

DAISe Thrombectomy System

DAISe Thrombectomy System for mechanical thrombectomy

Trial Locations (6)

31059

Hôpital Purpan, Toulouse

33000

CHU Pellegrin, Bordeaux

54035

CHU Urbains, Nancy

94270

CHU Bicetre Paris, Paris

Unknown

CHU Montpellier, Montpellier

Groupe Hospitalier Pitie-Salpetriere, Paris

Sponsors
All Listed Sponsors
lead

MIVI Neuroscience, Inc.

INDUSTRY

NCT05139147 - DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter